Contents
{UN} Unit 1{/UN}
{UT}Foundations for Drug Therapy in Nursing{/UT}
{CN}Chapter 1{/CN}
{CT}Nursing Management in Drug Therapy{/CT}
Diane S. Aschenbrenner
{CN}Chapter 2{/CN}
{CT}Pharmaceuticals: Development, Safeguards, and Delivery{/CT}
Samantha J. Venable
{CN}Chapter 3{/CN}
{CT}Drug Administration{/CT}
Diane S. Aschenbrenner
{UN} Unit 2{/UN}
{UT}Core Drug Knowledge{/UT}
{CN}Chapter 4{/CN}
{CT}Pharmacotherapeutics, Pharmacokinetics, and Pharmacodynamics{/CT}
Diane S. Aschenbrenner
{CN}Chapter 5{/CN}
{CT}Adverse Effects and Drug Interactions{/CT}
Diane S. Aschenbrenner
{UN}Unit 3{/UN}
{UT}Core Patient Variables{/UT}
{CN}Chapter 6{/CN}
{CT}Life Span: Children{/CT}
Diane S. Aschenbrenner
{CN}Chapter 7{/CN}
{CT}Life Span: Pregnant or Breast-Feeding Women{/CT}
Diane S. Aschenbrenner
{CN}Chapter 8{/CN}
{CT}Life Span: Older Adults{/CT}
Diane S. Aschenbrenner
{CN}Chapter 9{/CN}
{CT}Lifestyle: Substance Abuse{/CT}
Samantha J. Venable
{CN}Chapter 10{/CN}
{CT}Lifestyle, Diet, and Habits: Nutrition and Complementary Medications{/CT}
Samantha J. Venable
{CN}Chapter 11{/CN}
{CT}Environment: Influences on Drug Therapy{CT}
Samantha J. Venable
{CN}Chapter 12{/CN}
{CT}Culture and Inherited Traits: Considerations in Drug Therapy{/CT}
Diane S. Aschenbrenner
{UN}Unit 4{/UN}
{UT}Peripheral Nervous System Drugs{/UT}
{CN}Chapter 13{/CN}
{CT}Drugs Affecting Adrenergic Function{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include epinephrine, phenylephrine, clonidine, dopamine, fenoldopam, prazosin, and propranolol.
{CN}Chapter 14{/CN}
{CT}Drugs Affecting Cholinergic Function{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include pilocarpine, nicotine, neostigmine, and atropine.
{UN}Unit 5{/UN}
{UT}Central Nervous System Drugs{/UT}
{CN}Chapter 15{/CN}
{CT}Drugs Producing Anesthesia and Neuromuscular Blocking{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include isoflurane, propofol, lidocaine, tubucurarine, succinylcholine
{CN}16{/CN}
{CT}Drugs Relieving Anxiety and Producing Sleep{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include lorazepam.
{CN}Chapter 17{/CN}
{CT}Drugs Treating Mood Disorders{/CT}
Bernard Keenan
The prototypes in this chapter include sertraline, nortriptyline, phenelzine, and lithium carbonate.
{CN}Chapter 18{/CN}
{CT}Drugs Treating Thought Disorders{/CT}
Bernard Keenan
The prototypes in this chapter include haloperidol, olanzapine, and rivastigmine.
{CN}Chapter 19{/CN}
{CT}Drugs Treating Seizure Disorders{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include phenytoin and ethosuximide.
{CN}Chapter 20{/CN}
{CT}Drugs Affecting Muscle Spasm and Spasticity{/CT}
Samantha J. Venable
The prototypes in this chapter include cyclobenzaprine, baclofen, and dantrolene.
{CN}Chapter 21{/CN}
{CT}Drugs Treating Parkinson Disease and Other Movement Disorders{/CT}
Samantha J. Venable
The prototypes in this chapter include carbidopa-levodopa, riluzole, and glatiramer.
{CN}Chapter 22{/CN}
{CT}Drugs Stimulating the Central Nervous System{/CT}
Samantha J. Venable
The prototypes in this chapter include dextroamphetamine, sibutramine, and caffeine.
{UN}Unit 6{/UN}
{UT}Analgesic and Anti-inflammatory Drugs{/UT}
{CN}Chapter 23{/CN}
{CT}Drugs Treating Severe Pain{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include morphine, codeine, and pentazocine.
{CN}Chapter 24{/CN}
{CT}Drugs Treating Headache, Fever, and Inflammation{/CT}
Samantha J. Venable
The prototypes in this chapter include aspirin, ibuprofen, acetaminophen, and sumatriptan.
{CN}Chapter 25{/CN}
{CT}Drugs Treating Arthritis and Gout{/CT}
Samantha J. Venable
The prototypes in this chapter include methotrexate, colchicine, and probenecid.
{UN}Unit 7{/UN}
{UT}Cardiovascular and Renal System Drugs{/UT}
{CN}Chapter 26{/CN}
{CT}Drugs Affecting Cardiac Rhythm{/CT}
Barbara van de Castle
The prototypes in this chapter include quinidine, amiodarone, verapamil, and sodium polystyrene sulfonate.
{CN}Chapter 27{/CN}
{CT}Drugs Affecting Blood Pressure{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include captopril, losartan, eplerenone, labetalol, clonidine, hydralazine, nitroprusside, and dopamine.
{CN}Chapter 28{/CN}
{CT}Drugs Treating Congestive Heart Failure{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include digoxin.
{CN}Chapter 29{/CN}
{CT}Drugs Treating Angina{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include nitroglycerin.
{CN}Chapter 30{/CN}
{CT}Drugs Affecting Lipid Levels{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include lovastatin.
Chapter 31
Drugs Affecting Coagulation
Diane S. Aschenbrenner
The prototypes in this chapter include heparin, warfarin, clopidogrel, pentoxifylline, alteplase, recombinant, antihemophilic factor, and aminocaproic acid.
Chapter 32
Drugs Affecting Diuresis
Diane S. Aschenbrenner
The prototypes in this chapter include hydrochlorothiazide, furosemide, triamterene, mannitol, acetazolamide, and tolterodine.
{UN}Unit 8{/UN}
{UT}Hematopoietic and Immune System Drugs{/UT}
{CN}Chapter 33{/CN}
{CT}Drugs Affecting Hematopoiesis{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include epoetin alpha, filgrastim, and oprelvekin (interleukin 11).
{CN}Chapter 34 {/CN}
{CT}Drugs Affecting the Immune Response{/CT}
Brenda Shelton
The prototypes in this chapter include interferon alfa-2a, rituximab, and cyclosporine.
{UN}Unit 9{/UN}
{UT}Chemotherapeutic Drugs{/UT}
{CN}Chapter 35{/CN}
{CT}Drugs That Are Cell Cycle-Specific{/CT}
Delia Bacquiran
The prototypes in this chapter include 5-fluorouracil, vincristine, etoposide, paclitaxel, topotecan, and hydroxyurea.
{CN}Chapter 36{/CN}
{CT}Drugs That Are Cell Cycle-Nonspecific{/CT}
Delia Bacquiran
The prototypes in this chapter include cyclophosphamide, carmustine, doxorubicin HCl, and tamoxifen.
{UN}Unit 10{/UN}
{UT}Antimicrobial Drugs{/UT}
{CN}Chapter 37{/CN}
{CT}Principles of Antibiotic Therapy{/CT}
Samantha J. Venable
{CN}Chapter 38{/CN}
{CT}Antibiotics Affecting the Bacterial Cell Wall{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include penicillin G, cefazolin, vancomycin, and daptomycin.
{CN}Chapter 39{/CN}
{CT}Antibiotics Affecting Protein Synthesis{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include gentamicin, clindamycin, erythromycin, linezolid, quinupristin/dalfopristin, tetracycline, and chloramphenicol.
{CN}Chapter 40{/CN}
{CT}Drugs That Are Miscellaneous Antibiotics{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include ciprofloxacin.
{CN}Chapter 41{/CN}
{CT}Drugs Treating Urinary Tract Infections{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include sulfamethoxazole-trimethoprim.
{CN}Chapter 42{/CN}
{CT}Drugs Treating Mycobacterial Infections{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include isoniazid and rifampin.
{CN}Chapter 43{/CN}
{CT}Drugs Treating Viral and Fungal Diseases{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include acyclovir, amphotericin B, and fluconazole.
{CN}Chapter 44{/CN}
{CT}Drugs Treating HIV Infection and AIDS{/CT}
Samantha J. Venable
The prototypes discussed in this chapter include zidovudine, nevirapine, saquinavir, and enfuvirtide.
{CN}Chapter 45{/CN}
{CT}Drugs Treating Parasitic Infections{/CT}
The prototypes discussed in this chapter include chloroquine, metronidazole, pentamidine isethionate, mebendazole, and permethrin.
{UN}Unit 11{/UN}
{UT}Respiratory Drugs{/UT}
{CN}Chapter 46{/CN}
{CT}Drugs Affecting the Upper System{/CT}
Samantha J. Venable
The prototypes in this chapter include dextromethorphan, pseudoephedrine, fexofenadine, and guaifenesin.
{CN}Chapter 47{/CN}
{CT}Drugs Affecting the Lower System{/CT}
Samantha J. Venable
The prototypes in this chapter include acetylcysteine, albuterol, ipratropium bromide, theophylline, flunisolide, cromolyn sodium, and zafirlukast.
{UN}Unit 12{/UN}
{UT}Gastrointestinal Tract Drugs{/UT}
{CN}Chapter 48CN}
{CT}Drugs Affecting the Upper Gastrointestinal Tract{/CT}
Kathie Judy Guth
The prototypes in this chapter include omeprazole, ranitidine, aluminum hydroxide with magnesium hydroxide, metoclopramide, pancrelipase, orlistat, and ondansetron.
{CN}Chapter 49/CN}
{CT}Drugs Affecting the Lower Gastrointestinal Tract{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include simethicone, diphenoxylate HCl with atropine sulfate, magnesium hydroxide, and alosetron.
{UN}Unit 13{/UN}
{UT}Endocrine Drugs{/UT}
{CN}Chapter 50{/CN}
{CT}Drugs Affecting Pituitary, Thyroid, Parathyroid, and Hypothalamic Function {/CT}
Joyce Vazzano
Prototypes in this chapter include somatropin, desmopressin, levothyroxine, calcitonin, salmon, and calcitriol.
{CN}Chapter 51{/CN}
{CT}Drugs Affecting Corticosteroid Levels{/CT}
Samantha J. Venable
Prototypes in this chapter include prednisone, fludrocortisone, and aminoglutethimide.
{CN}Chapter 52{/CN}
{CT}Drugs Affecting Blood Glucose Levels{/CT}
Andrew Benson
The prototypes in this chapter include regular insulin, glyburide, metformin, and glucagon.
{CN}Chapter 53{/CN}
{CT}Drugs Affecting Men's Health and Sexuality {/CT}
Shari Lynn
The prototypes in this chapter include testosterone, sildenafil, finasteride, and minoxidil (topical).
{CN}Chapter 54{/CN}
{CT}Drugs Affecting Women's Health and Sexuality{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include conjugated estrogen, progesterone, and alendronate.
{CN}Chapter 55{/CN}
{CT}Drugs Affecting Uterine Motility{/CT}
Diane S. Aschenbrenner
The prototypes in this chapter include oxytocin and terbutaline.
Appendices
A
Supplemental Canadian Drug Information
Samantha J. Venable
B
Diagnostic Imaging Agents
Samantha J. Venable
C
Enzyme or Débridement Therapy
Samantha J. Venable
D
Enteral and Nutritional Supplements
Samantha J. Venable
E
Parenteral Nutrition
Samantha J. Venable
F
Antidotes
Samantha J. Venable
G
Immunizations
Samantha J. Venable
H
Antiemetic Drugs
Samantha J. Venable
I
Therapeutic and Toxic Levels of Selected Drugs
Samantha J. Venable
J
Drug-Induced Photosensitivity
Samantha J. Venable